Next Article in Journal
Inherent Bias in Artificial Intelligence-Based Decision Support Systems for Healthcare
Previous Article in Journal
Maxillary Implant-Supported Overdentures: Mechanical Behavior Comparing Individual Axial and Bar Retention Systems. A Cohort Study of Edentulous Patients
Open AccessArticle

Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration

1
Laboratory of Histology and Embryology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
2
Department of Oral and Maxillofacial Surgery, University Hospital of Erlangen, 91054 Erlangen, Germany
*
Author to whom correspondence should be addressed.
Medicina 2020, 56(3), 140; https://doi.org/10.3390/medicina56030140 (registering DOI)
Received: 23 February 2020 / Revised: 11 March 2020 / Accepted: 11 March 2020 / Published: 19 March 2020
Background and objectives: Bisphosphonates represent selective inhibitors of excess osteoblastic bone resorption that characterizes all osteopathies, targeting osteoclasts and their precursors. Their long-term administration in postmenopausal women suffering from osteoporosis has resulted in neural adverse effects. The current study focuses on the research of possible alterations in the femoral nerve, caused by bisphosphonates. We hypothesized that bisphosphonates, taken orally (per os), may produce degenerative changes to the femoral nerve, affecting lower-limb posture and walking neuronal commands. Materials and Methods: In order to support our hypothesis, femoral nerve specimens were extracted from ten female 12-month-old Wistar rats given 0.05 milligrams (mg) per kilogram (kg) of body weight (b.w.) per week alendronate per os for 13 weeks and from ten female 12-month-old Wistar rats given normal saline that were used as a control group. Specimens were studied using immunohistochemistry for selected antibodies NeuN (Neuronal Nuclear Protein), a protein located within mature, postmitotic neural nucleus, and cytosol and Sox10 (Sex-determining Region Y (SRY)—High-Motility Group (HMG)—box 10). The latter marker is fundamental for myelination of peripheral nerves. Obtained slides were examined under a light microscope. Results: Samples extracted from rats given alendronate were more Sox10 positive compared to samples of the control group, where the marker’s expression was not so intense. Both groups were equally NeuN positive. Our results are in agreement with previous studies conducted under a transmission electron microscope. Conclusions: The suggested pathophysiological mechanism linked to histological alterations described above is possibly related to toxic drug effects on Schwann and neuronal cells. Our hypothesis enhances the existing scientific evidence of degenerative changes present on femoral nerve following bisphosphonates administration, indicating a possible relationship between alendronate use and neuronal function. View Full-Text
Keywords: bisphosphonates; femoral nerve; immunohistochemistry; NeuN; Sox10 bisphosphonates; femoral nerve; immunohistochemistry; NeuN; Sox10
Show Figures

Figure 1

MDPI and ACS Style

Karakousis, V.A.; Liouliou, D.; Loula, A.; Kagianni, N.; Dietrich, E.-M.; Meditskou, S.; Sioga, A.; Papamitsou, T. Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration. Medicina 2020, 56, 140.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop